Allurion Technologies ALURD
ALURD
$3.28 -0.11 (-3.24%)
At close: Aug 18, 2026 · 4:00 PM UTC

Allurion Technologies (ALURD) Liabilities and Shareholders Equity (2022 - 2026)

Allurion Technologies' (ALURD) quarterly Liabilities and Shareholders Equity came in at $14.0 million in Q1 2026, down 63.57% YoY from $38.4 million in Q1 2025, and down 11.27% on a QoQ basis from $15.8 million in Q4 2025.

Allurion Technologies (ALURD) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends

Allurion Technologies (ALURD) has 5 years of Liabilities and Shareholders Equity data on file, last reported at $14.0 million in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity fell 63.57% year-over-year to $14.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $76.1 million (down 54.84% YoY) and the FY2025 annual result came in at $15.8 million, down 51.93% from the prior year.
  • Liabilities and Shareholders Equity declined to $14.0 million in Q1 2026, from $15.8 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $120.7 million in Q3 2023 to a low of $14.0 million in Q1 2026.
  • A 5-year average of $46.2 million and a median of $46.6 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity surged 39.6% — and 2025, when it tumbled 64.22%.
  • Tracing ALURD's Liabilities and Shareholders Equity over 5 years: stood at $51.4 million in 2022, then jumped by 39.6% to $71.7 million in 2023, then tumbled by 54.24% to $32.8 million in 2024, then slumped by 51.93% to $15.8 million in 2025, then slipped by 11.27% to $14.0 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $14.0 million (Q1 2026), $15.8 million (Q4 2025), and $18.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 199.44 Bn 193.84 Bn 7.27 Bn 109.22 Bn
2 Stryker 127.32 Bn 123.85 Bn 4.50 Bn 47.93 Bn
3 Medtronic 118.87 Bn 109.65 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 73.47 Bn 72.93 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.90 Bn 47.65 Bn 1.35 Bn 13.87 Bn
6 Dexcom 34.30 Bn 32.36 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 33.74 Bn 31.63 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn 31.04 Bn
9 Steris 23.05 Bn 22.56 Bn 684.20 Mn 10.74 Bn
10 Allurion Technologies 49.18 Mn 44.13 Mn 1.23 Mn 14.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 14.00 Mn
Dec 31, 2025 15.77 Mn
Sep 30, 2025 18.14 Mn
Jun 30, 2025 28.17 Mn
Mar 31, 2025 38.41 Mn
Dec 31, 2024 32.81 Mn
Sep 30, 2024 50.70 Mn
Jun 30, 2024 46.55 Mn
Mar 31, 2024 59.99 Mn
Dec 31, 2023 71.71 Mn
Sep 30, 2023 120.69 Mn
Jun 30, 2023 52.15 Mn
Dec 31, 2022 51.37 Mn